| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 WHO Measles/Rubella European RRL and NRC Measles, Mumps, Rubella, Robert Koch-Institut, Nordufer 20, D-13353 Berlin, Germany
2 Institut für Virologie und Immunbiologie, University of Würzburg, Würzburg, Germany
3 Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands
Correspondence
Sabine Santibanez
SantibanezS{at}rki.de
Measles virus (MV) infection and vaccination induce long-lasting immunity and neutralizing-antibody responses that are directed against the MV haemagglutinin (H) and the fusion (F) protein. A new MV genotype, D7, emerged recently in western Germany and rapidly replaced the long-term endemically circulating genotypes C2 and D6. Analysis of the H gene of C2, D6, D7 and vaccine viruses revealed uniform sequences for each genotype. Interestingly, a consistent exchange of seven distinct amino acids in the D7 H was observed when compared with residues shared between C2, D6 and vaccine viruses, and one exchange (D416
N) in the D7 H was associated with an additional N-linked glycosylation. In contrast, the F gene is highly conserved between MVs of these genotypes. To test whether the D7 H protein escapes from antibody responses that were raised against earlier circulating or vaccine viruses, the neutralizing capacity of mAbs recognizing seven distinct domains on the H of an Edmonston-related MV was compared. The mAbs revealed a selective and complete loss of two neutralizing epitopes on the D7 H when compared with C2, D6 and vaccine viruses. To assess whether these alterations of the D7 H affect the neutralizing capacity of polyclonal B-cell responses, genotype-specific antisera were produced in cotton rats. However, no significant genotype-dependent difference was found. Likewise, human sera obtained from vaccinees (n=7) and convalescents (n=6) did not distinguish between the MV genotypes. Although the hypothesis of selection of D7 viruses by pre-existing neutralizing antibodies is compatible with the differing pattern of neutralizing epitopes on the H protein, it was not confirmed by the results of MV neutralization with polyclonal sera.
Present address: College of Veterinary Medicine, Ohio State University, Columbus, OH, USA.
Present address: Institute for Virology, University of Düsseldorf, Düsseldorf, Germany.
This article has been cited by other articles:
|
|
 |
|
  T. Finsterbusch, A. Wolbert, I. Deitemeier, K. Meyer, M. M. Mosquera, A. Mankertz, and S. Santibanez Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope J. Gen. Virol., November 1, 2009; 90(11): 2739 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Simek, W. Rida, F. H. Priddy, P. Pung, E. Carrow, D. S. Laufer, J. K. Lehrman, M. Boaz, T. Tarragona-Fiol, G. Miiro, et al. Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm J. Virol., July 15, 2009; 83(14): 7337 - 7348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. H. Ruigrok and D. Gerlier Structure of the measles virus H glycoprotein sheds light on an efficient vaccine PNAS, December 26, 2007; 104(52): 20639 - 20640. [Full Text] [PDF]
|
|
|
|
|
|
R. L. de Swart, S. Yuksel, and A. D. M. E. Osterhaus Relative Contributions of Measles Virus Hemagglutinin- and Fusion Protein-Specific Serum Antibodies to Virus Neutralization J. Virol., September 1, 2005; 79(17): 11547 - 11551. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
